Source Says Riken To Announce Failure In Replicating STAP Cells
This article was originally published in PharmAsia News
Executive Summary
Japan's Riken Institute, home to the widely disputed stem-cell breakthrough study, is expected to announce failure in replicating the published research that said that skin cells put under stress became iPS cells.